.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Myeloid Leukemia
. Ed(S): Iland, Harry; Hertzberg, Mark; Marlton, Paula
€ 129.44
FREE Delivery in Ireland
Description for Myeloid Leukemia
Hardback. Brings together a collection of reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. In addition to gene rearrangements, this work also covers other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression. Editor(s): Iland, Harry; Hertzberg, Mark; Marlton, Paula. Series: Methods in Molecular Medicine. Num Pages: 320 pages, 69 black & white illustrations, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 27. Weight in Grams: 663.
A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered. ... Read more
A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered. ... Read more
Product Details
Format
Hardback
Publication date
2005
Publisher
Humana Press Inc. United States
Number of pages
320
Condition
New
Series
Methods in Molecular Medicine
Number of Pages
307
Place of Publication
Totowa, NJ, United States
ISBN
9781588294852
SKU
V9781588294852
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Myeloid Leukemia